Skip to content

Dortmund, 25th November 2025

Das Foto zeigt Doktorandin Nora Pauly im Labor am Konfokalmikroskop.
© ISAS

Nora Pauly is a doctoral candidate in the ISAS Bioimaging group. She is conducting research on the consequences of heart attacks.

Nora Pauly (27) is working alongside 32 other doctoral candidates to investigate the potential long-term consequences of heart attacks. The immunologist is pursuing her doctorate in the Research Training Group »RTG 2989 Targeting Cellular Interfaces in Reperfused Acute Myocardial Infarction (TCI repAMI) « (see info box). To learn more about her work in the Bioimaging research group at ISAS, the editorial team asked her to complete the following sentences.

  • I am doing my PhD at ISAS on…

    a specific type of immune cell: macrophages. I am particularly interested in the differences between various subtypes of macrophages before and after a heart attack. We suspect that these subtypes perform different functions during a heart attack and are influenced by a specific cytokine, the macrophage migration inhibitory factor (MIF). I intend to investigate this process in more detail by "switching off" this factor and examining its impact on the various macrophage subtypes in the hearts of mice after a heart attack, using a confocal microscope, for example.

  • This is important for research on heart attacks because…

    MIF could be a potential therapeutic target for reducing consequential damage. Previous research has revealed how reperfusion injury – the damage that occurs after blood supply is restored to a previously occluded vessel – develops. However, it remains unclear how this damage can be reduced.

  • In the laboratory, I work with…

    three different devices. Using a confocal microscope, I can examine the spatial distribution of macrophage subtypes in detail. For example, I can see whether they are in the atrium, ventricle or apex of the heart. After a heart attack, the microscope allows me to clearly see where the dead heart muscle cells are and where the vessel has been constricted. I can identify individual subtypes using a flow cytometer. Although I cannot distinguish areas of the heart as clearly with the flow cytometer as with the confocal microscope, the analysis is more sensitive and provides information about the number of subtypes present. In addition, I will soon be working with a light-sheet fluorescence microscope. This will enable me to examine the entire heart of a mouse at once and view the macrophage populations in three dimensions.

  • Through the Research Training Group of the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG), I gain…

    very detailed insight and a wealth of background knowledge on heart attack research. This is thanks to numerous lectures designed to bring doctoral students from ISAS and the clinic up to the same level of knowledge. Clinic visits, which take place twice a year, also provide an opportunity to learn first-hand about the processes involved in patient care. Feedback at seminars, where we present the status of our research, and at various meetings with professors helps me stay on track scientifically and get the most out of my dissertation project.

About the DFG Research Training Group »TCI repAMI«

The Research Training Group »RTG 2989 Targeting Cellular Interfaces in Reperfused Acute Myocardial Infarction (TCI repAMI) « is funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) and focuses on the consequential damages of heart attacks. Emergency reperfusion – the rapid reopening of a coronary artery – can lead to inflammatory processes. These processes are based on an interaction between specific immune, vascular, and heart muscle cells. TCI repAMI aims to analyse this interaction to identify new treatment options for heart attack patients.

Following the bed-to-bench-to-bed principle, the researchers first identify a clinical problem, before creating an experimental design in the laboratory. After analysing and evaluating the research data, the findings are taken back to the clinic for contextualisation at the patient's bedside.

Interdisciplinary training is one of the programme's key components. Tandem teams, consisting of two experts from clinical practice and fundamental research, supervise a total of 33 doctoral students.

TCI repAMI is funded by the DFG under project number 449437943.

(Protokoll: Anna Becker)

Share

Further articles

New Framework for Efficient Image Data Analysis in Biomedicine

How can AI be used optimally in bioimaging research? A team of international researchers and scientists led by Dr Jianxu Chen from ISAS has developed a framework designed to make it easier for biomedical scientists to work with data-centric AI. Using the example of vascular segmentation, the authors of the publication in the journal npj imaging now demonstrate the advantages of the new framework.

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.